TBX19 and Hypoglycemia: All neonates with TBX19 mutations developed neonatal hypoglycemia and had complete IAD, but the incidences of these and other clinical signs (e.g., long-term cholestatic jaundice and seizures) were lower in the two groups without TBX19 mutations.